ADVANCES IN GENETIC THERAPY FOR RARE GENETIC DISEASES

Abstract

Rare genetic diseases represent a diverse group of inherited conditions that affect a limited number of individuals worldwide. Historically, these diseases have been a significant challenge due to the lack of effective treatments and the scant attention they receive from conventional medical research. However, in recent decades, remarkable advances in gene therapy have illuminated a promising path forward for patients facing these rare diseases. This article reviews and highlights the most recent advances in gene therapy for rare genetic diseases. The scientific basis of this therapeutic approach, including viral vectors, gene editing, and personalized gene therapies, is discussed. Examples of successful clinical trials are presented, demonstrating encouraging results in diseases such as cystic fibrosis, spinal muscular atrophy and sickle cell anemia. Additionally, ongoing challenges associated with gene therapy are addressed, including issues of effective delivery, costs, regulation, and ethical considerations. The importance of multidisciplinary collaboration between scientists, clinicians, regulators and patients is emphasized as key to future progress. Ultimately, this article highlights that although there are challenges to overcome, gene therapy offers new hope for patients with rare genetic diseases. Continued advancement in this area has the potential to transform lives, changing the narrative of rare genetic diseases from a lack of effective treatment to the real promise of more precise and affordable therapies.